<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01998308</url>
  </required_header>
  <id_info>
    <org_study_id>October6U-0001</org_study_id>
    <nct_id>NCT01998308</nct_id>
  </id_info>
  <brief_title>Comparison Between Four Types of Single Dose Hyaluronic Acid Injection in Patients With Knee Osteoarthritis</brief_title>
  <official_title>Intra-articular Hyaluronic Acid Knee Injection: Randomized Control Trial.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>October 6 University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>October 6 University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Study design:&#xD;
&#xD;
      Allocation: Randomized. Endpoint Classification: Comparative Study. Intervention model:&#xD;
      Parallel Assignment. Masking: Double Blind (Subject, Assessed) Primary purpose: Comparison.&#xD;
&#xD;
      Official Title: Intra-articular hyaluronic acid knee injection: randomized control trail.&#xD;
&#xD;
      Primary outcome measures:&#xD;
&#xD;
        -  Lower extremity functional scale&#xD;
&#xD;
        -  Visual analogue scale&#xD;
&#xD;
        -  Range of motion&#xD;
&#xD;
        -  Kellgren and Lawrence class grade Estimated enrollment: 100 Study start date: December&#xD;
           2012 Estimated study completion date: June 2013 Estimated primary completion date:&#xD;
           December 2013&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study include:&#xD;
&#xD;
      200 knees, 50 knees will have single injection of Crespine gel, and 50 knees will have single&#xD;
      injection of 2 ampules of Intragel, also 50 knees will have single injection of Crespine plus&#xD;
      gel and 50 knees will have single injection of Monovisc The patient will be randomized to&#xD;
      Crespine gel or to Intragel, and Crespine Plus gel or to Monovisc&#xD;
&#xD;
      Inclusion Criteria: patients with Osteoarthritis grade II and III according to Kellgren and&#xD;
      Lawrence grading were included.&#xD;
&#xD;
      Exclusion Criteria: patients with autoimmune illnesses, active inflammation or infected&#xD;
      processes, anticoagulant, and known allergy to hyaluronic acid.&#xD;
&#xD;
      Target parameters:&#xD;
&#xD;
        -  Lower extremity functional scale&#xD;
&#xD;
        -  Visual analogue scale&#xD;
&#xD;
        -  Range of motion&#xD;
&#xD;
        -  Kellgren and Lawrence class grade&#xD;
&#xD;
      Eligibility:&#xD;
&#xD;
      Ages Eligible for Study: 20 years to 70 years Genders Eligible for Study: both Accepts&#xD;
      Healthy Volunteers: no&#xD;
&#xD;
      Criteria&#xD;
&#xD;
      Inclusion Criteria:&#xD;
&#xD;
        -  Age of patients between 20 and 70 years&#xD;
&#xD;
        -  patients with Osteoarthritis grade II and III according to Kellgren and Lawrence grading&#xD;
&#xD;
      Exclusion Criteria:&#xD;
&#xD;
        -  Autoimmune illnesses&#xD;
&#xD;
        -  Active inflammation or infected processes&#xD;
&#xD;
        -  Anticoagulant&#xD;
&#xD;
        -  Known allergy to hyaluronic acid.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <study_type>Observational [Patient Registry]</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Ecologic or Community</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <target_duration>24 Months</target_duration>
  <primary_outcome>
    <measure>Lower extremity functional scale</measure>
    <time_frame>up to 52 weeks</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Visual analog scale</measure>
    <time_frame>up to 52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Kellgren and lawrence class grade</measure>
    <time_frame>up to 52 weeks</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Range of motion</measure>
    <time_frame>up to 52 weeks</time_frame>
  </secondary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">200</enrollment>
  <condition>Osteoarthritis</condition>
  <arm_group>
    <arm_group_label>Group 1</arm_group_label>
    <description>50 Knees will have single injection of Crespine gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 2</arm_group_label>
    <description>50 Knees will have single injection of 2 ampules of intragel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 3</arm_group_label>
    <description>50 knees will have single injection of crespine plus gel</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group 4</arm_group_label>
    <description>50 knees will have single injection of Monovisc</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crespine gel</intervention_name>
    <description>50 Knees will have single injection of Crespine gel</description>
    <arm_group_label>Group 1</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Intragel</intervention_name>
    <description>50 Knees will have single injection of 2 ampules of Intragel</description>
    <arm_group_label>Group 2</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Crespine plus gel</intervention_name>
    <description>50 Knees will have single injection of Crespine Plus Gel</description>
    <arm_group_label>Group 3</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Monovisc</intervention_name>
    <description>50 Knees will have single injection of Monovisc</description>
    <arm_group_label>Group 4</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patient with knee osteoarthiritis&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age of patients between 20 and 70 years&#xD;
&#xD;
          -  patients with Osteoarthritis grade II and III according to Kellgren and Lawrence&#xD;
             grading&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Autoimmune illnesses&#xD;
&#xD;
          -  Active inflammation or infected processes&#xD;
&#xD;
          -  Anticoagulant&#xD;
&#xD;
          -  Known allergy to hyaluronic acid.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mahmoud A Hafez, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>October 6 University</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Abdullah I Ammoura, Researcher</last_name>
    <role>Study Chair</role>
    <affiliation>Bone and Joint Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mahmoud A Hafez, Professor</last_name>
    <phone>002 0100 1116624</phone>
    <email>mhafez@msn.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Abdullah I Ammoura, Researcher</last_name>
    <phone>00201118581127</phone>
    <email>abdala.ammora@mhafez.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>October 6 University</name>
      <address>
        <city>six October city</city>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mahmoud A Hafez, Professor</last_name>
      <phone>00201001116624</phone>
      <email>mhafez@msn.com</email>
    </contact>
    <contact_backup>
      <last_name>Abdullah I Ammoura, Researcher</last_name>
      <phone>00201118581127</phone>
      <email>mixecano1991@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Mahmoud A Hafez, professor</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>September 2015</verification_date>
  <study_first_submitted>November 16, 2013</study_first_submitted>
  <study_first_submitted_qc>November 23, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 28, 2013</study_first_posted>
  <last_update_submitted>September 28, 2015</last_update_submitted>
  <last_update_submitted_qc>September 28, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">September 30, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>October 6 University</investigator_affiliation>
    <investigator_full_name>Mahmoud A Hafez, MSc Orth, Dip SICOT, FRCS Ed, MD</investigator_full_name>
    <investigator_title>Mahmoud A Hafez</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Osteoarthritis</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hyaluronic Acid</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>February 23, 2021</submitted>
    <returned>March 17, 2021</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

